Advocates call for lower cost, greater access to new injectable PrEP drug

What should be the price for lenacapavir?
by Rick Guasco
image of medical profession using a heavy gauge syringe to draw medication from a vial

Survey seeks views from people living with HIV about long-acting injectable treatment

ADAP Advocacy launches survey about long-acting injectable treatment
by Rick Guasco
a young doctor of color who is a social media influencer walks about HIV

Trusted voices

COMMUNITY FORUM
by Jonathan Ayala Treatment Program Coordinator, NMAC
picture of the AIDS Quilt on display at the National Mall in Washington, D.C.

New documentary considers the last mile to ‘Ending HIV in America’

Personal stories are interwoven into a larger picture of HIV treatment—past, present, and future
by Rick Guasco
infographic depicting percentage of PrEP users by age group, 2021

PrEP use data comes to life in new graphics

AIDSVu's new infographics illustrate PrEP use data
By Rick Guasco
Young male aboard Chicago commuter train in front of public service ad for PrEP

Campaña bilingual para PrEP en Chicago

Bilingual PrEP campaign launches in Chicago
story and photo by Enid Vázquez
medical research image

Report from the community HIV cure research workshop

HIV cure research highlights
By Karine Dubé, Lynda Dee, Jeff Berry, and Michael Louella
female hand holding up a dapivirine ring

Virtual CROI 2022: The dapivirine ring vs. the FDA

This PrEP method is still a desirable option in the U.S. for cisgender women
By
man holding up an at-home COVID-19 test

Virtual CROI 2022: Testing and treating

Highlights from Virtual CROI 2022
By
gilded portrait frame

When HIV therapy fails: Terms of ART

A treatment glossary
By
Subscribe to HIV Prevention